Dubé L M, Ho-Ngoc A, Davies R F, Beanlands D S, Mousseau N, McGilveray I J
Res Commun Chem Pathol Pharmacol. 1983 Dec;42(3):401-15.
It has been suggested that heparin-induced increases in drug free fraction are largely artifactual as a result of continued in vitro activity of lipoprotein lipases after blood samples collection. The influence of different concentrations of protamine (1.0, 2.5, 5.0 and 10.0 mg/ml), an inhibitor of lipoprotein lipases, on lidocaine free fraction was studied before (control) and 10 min after heparinization (3000 IU) in 7 cardiac catheterized patients. Heparin increased the mean free fraction of lidocaine by 85% (p less than 0.001) and was associated with more than 2-fold increases in free fatty acids (FFAs). The presence of protamine at 2.5, 5.0 and 10.0 mg/ml diminished both the heparin-induced elevation of lidocaine free fraction (p less than 0.001) and FFAs (p less than 0.001). At a protamine concentration of 10.0 mg/ml, the FFAs remained higher than control value (p less than 0.05) while the free fraction was not different from control preheparin value. There were significant relationships (p less than 0.01) between log protamine concentration and the changes in both free fraction (r2 = 0.906) and FFAs (r2 = 0.931). The inhibitor also reduced (p less than 0.01) the lidocaine free fraction in control samples but these changes were not correlated with changes of FFAs. These results indicate that it is impossible, at this point, to abolish the artifactual effect of heparin without altering protein binding of lidocaine.
有人提出,肝素诱导的药物游离分数增加在很大程度上是人为造成的,这是由于采血后脂蛋白脂肪酶在体外持续发挥作用。在7例接受心导管插入术的患者中,研究了不同浓度的鱼精蛋白(1.0、2.5、5.0和10.0mg/ml)(脂蛋白脂肪酶的抑制剂)在肝素化(3000IU)前(对照)和肝素化后10分钟对利多卡因游离分数的影响。肝素使利多卡因的平均游离分数增加了85%(p<0.001),并与游离脂肪酸(FFA)增加2倍以上相关。2.5、5.0和10.0mg/ml的鱼精蛋白可减少肝素诱导的利多卡因游离分数升高(p<0.001)和FFA升高(p<0.001)。在鱼精蛋白浓度为10.0mg/ml时,FFA仍高于对照值(p<0.05),而游离分数与肝素化前对照值无差异。鱼精蛋白浓度对数与游离分数变化(r2=0.906)和FFA变化(r2=0.931)之间存在显著相关性(p<0.01)。该抑制剂还降低了(p<0.01)对照样品中的利多卡因游离分数,但这些变化与FFA变化无关。这些结果表明,目前在不改变利多卡因蛋白结合的情况下,不可能消除肝素的人为影响。